231 related articles for article (PubMed ID: 28102288)
1. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.
Yu H; Xia H; Tang Q; Xu H; Wei G; Chen Y; Dai X; Gong Q; Bi F
Sci Rep; 2017 Jan; 7():40802. PubMed ID: 28102288
[TBL] [Abstract][Full Text] [Related]
2. Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway.
Xu R; Shang C; Zhao J; Han Y; Liu J; Chen K; Shi W
Tumour Biol; 2015 Jun; 36(6):4091-100. PubMed ID: 25964092
[TBL] [Abstract][Full Text] [Related]
3. MACC1 mediates acetylcholine-induced invasion and migration by human gastric cancer cells.
Yang T; He W; Cui F; Xia J; Zhou R; Wu Z; Zhao Y; Shi M
Oncotarget; 2016 Apr; 7(14):18085-94. PubMed ID: 26919111
[TBL] [Abstract][Full Text] [Related]
4. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
5. M3 muscarinic receptor antagonists inhibit small cell lung carcinoma growth and mitogen-activated protein kinase phosphorylation induced by acetylcholine secretion.
Song P; Sekhon HS; Lu A; Arredondo J; Sauer D; Gravett C; Mark GP; Grando SA; Spindel ER
Cancer Res; 2007 Apr; 67(8):3936-44. PubMed ID: 17440109
[TBL] [Abstract][Full Text] [Related]
6. Muscarinic receptor M3 mediates cell proliferation induced by acetylcholine and contributes to apoptosis in gastric cancer.
Wang L; Zhi X; Zhang Q; Wei S; Li Z; Zhou J; Jiang J; Zhu Y; Yang L; Xu H; Xu Z
Tumour Biol; 2016 Feb; 37(2):2105-17. PubMed ID: 26346168
[TBL] [Abstract][Full Text] [Related]
7. Muscarinic type 3 receptor induces cytoprotective signaling in salivary gland cells through epidermal growth factor receptor transactivation.
Kajiya M; Ichimonji I; Min C; Zhu T; Jin JO; Yu Q; Almazrooa SA; Cha S; Kawai T
Mol Pharmacol; 2012 Jul; 82(1):115-24. PubMed ID: 22511543
[TBL] [Abstract][Full Text] [Related]
8. [M3 Muscarnic Receptor Antagonist Mediates Cell Proliferation Apoptosis
and Adhesion in Small Cell Lung Cancer].
Wu W; Zhang S; Hu C
Zhongguo Fei Ai Za Zhi; 2016 Mar; 19(3):113-21. PubMed ID: 27009814
[TBL] [Abstract][Full Text] [Related]
9. R2-8018 reduces the proliferation and migration of non-small cell lung cancer cells by disturbing transactivation between M3R and EGFR.
Lan L; Wang H; Yang R; Liu F; Bi Q; Wang S; Wei X; Yan H; Su R
Life Sci; 2019 Oct; 234():116742. PubMed ID: 31401315
[TBL] [Abstract][Full Text] [Related]
10. Acetylcholine inhibits tumor necrosis factor α activated endoplasmic reticulum apoptotic pathway via EGFR-PI3K signaling in cardiomyocytes.
Miao Y; Bi XY; Zhao M; Jiang HK; Liu JJ; Li DL; Yu XJ; Yang YH; Huang N; Zang WJ
J Cell Physiol; 2015 Apr; 230(4):767-74. PubMed ID: 25201632
[TBL] [Abstract][Full Text] [Related]
11. Blocking M2 muscarinic receptor signaling inhibits tumor growth and reverses epithelial-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC).
Zhao Q; Gu X; Zhang C; Lu Q; Chen H; Xu L
Cancer Biol Ther; 2015; 16(4):634-43. PubMed ID: 25778781
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine release by human colon cancer cells mediates autocrine stimulation of cell proliferation.
Cheng K; Samimi R; Xie G; Shant J; Drachenberg C; Wade M; Davis RJ; Nomikos G; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2008 Sep; 295(3):G591-7. PubMed ID: 18653726
[TBL] [Abstract][Full Text] [Related]
13. Teaching an Old Drug New Tricks: Agonism, Antagonism, and Biased Signaling of Pilocarpine through M3 Muscarinic Acetylcholine Receptor.
Pronin AN; Wang Q; Slepak VZ
Mol Pharmacol; 2017 Nov; 92(5):601-612. PubMed ID: 28893976
[TBL] [Abstract][Full Text] [Related]
14. Acetylcholine-induced activation of M3 muscarinic receptors stimulates robust matrix metalloproteinase gene expression in human colon cancer cells.
Xie G; Cheng K; Shant J; Raufman JP
Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G755-63. PubMed ID: 19221016
[TBL] [Abstract][Full Text] [Related]
15. Blocking Muscarinic Receptor 3 Attenuates Tumor Growth and Decreases Immunosuppressive and Cholinergic Markers in an Orthotopic Mouse Model of Colorectal Cancer.
Kuol N; Davidson M; Karakkat J; Filippone RT; Veale M; Luwor R; Fraser S; Apostolopoulos V; Nurgali K
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614038
[TBL] [Abstract][Full Text] [Related]
16. [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway].
Zhang XJ; Zhang L; Liu YP; Xu HM; Sun P; Song JG; Luo YH
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):181-6. PubMed ID: 23879997
[TBL] [Abstract][Full Text] [Related]
17. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
18. M3 muscarinic receptors promote cell survival through activation of the extracellular regulated kinase (ERK1/2) pathway.
Greenwood JM; Dragunow M
Eur J Pharmacol; 2010 Aug; 640(1-3):38-45. PubMed ID: 20519144
[TBL] [Abstract][Full Text] [Related]
19. Bile acid-induced proliferation of a human colon cancer cell line is mediated by transactivation of epidermal growth factor receptors.
Cheng K; Raufman JP
Biochem Pharmacol; 2005 Oct; 70(7):1035-47. PubMed ID: 16139803
[TBL] [Abstract][Full Text] [Related]
20. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
